«Vaccine used to treat cervical precancers
triggers immune cell response.»
Not exact matches
And using
cells from someone other than the cancer patient being treated might
trigger an
immune response against the foreign
cells.
An
immune response,
triggered by foreign neural stem
cells, could actually help attack tumors, says Evan Snyder, a stem
cell biologist at Sanford Burnham Prebys Medical Discovery Institute in San Diego, California, and one of the early pioneers of the idea of using stem
cells to attack tumors.
«We also showed that, once the NOD2 pathway
trigger is initiated, the
cells need a second, amplifying step to complete a full - strength
immune response.»
«Similarly,
triggering extra production of particular dendritic
cells could improve the
immune response to infections or vaccines.
George Klinman, an FDA immunologist and lead author of the report, speculates that dangling the protein in front of the
immune system in an unusual setting — on a muscle
cell — might be what
triggers the inappropriate
response.
However, some mice experienced dangerous levels of brain swelling, a side effect of the
immune response triggered by the engineered
cells, the researchers said, adding that extreme caution will be needed to introduce the approach in human clinical trials.
The experiments indicated that when dectin - 1 recognizes tropomyosin in house dust mites, shrimp or other common allergy -
triggering species it suppresses airway
cells» production of an
immune molecule, IL - 33, which otherwise would promote an allergic
response by
immune cells.
In GVHD, donor
cells trigger an
immune response that attacks normal tissues, leading to a chain reaction of cellular and molecular
responses that increase morbidity and mortality in these patients.
The JDF Center for Islet
Cell Transplantation will fund 32 researchers to focus on four main goals: Reversing the overactive immune response that kills islet cells; finding new sources for islet cell transplants, such as pigs or genetically engineered cells; persuading the body to accept the transplanted cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of transplantat
Cell Transplantation will fund 32 researchers to focus on four main goals: Reversing the overactive
immune response that kills islet
cells; finding new sources for islet
cell transplants, such as pigs or genetically engineered cells; persuading the body to accept the transplanted cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of transplantat
cell transplants, such as pigs or genetically engineered
cells; persuading the body to accept the transplanted
cells without immunosuppressive drugs that often
trigger worse side effects than the disease; and overcoming the technical difficulties of transplantation.
Researchers targeting colorectal cancer stem
cells — the root cause of disease, resistance to treatment and relapse — have discovered a mechanism to mimic a virus and potentially
trigger an
immune response to fight the cancer like an infection.
Antril, which is classified as an interleukin - 1 receptor antagonist, occupies the site on
cells lining blood vessels where interleukin - 1 docks before it
triggers an
immune response.
The central idea is to encode an antigen as RNA and inject that into the skin of the patient, whose own
cells then produce the protein that
triggers an
immune response, either to kill tumor
cells or to prevent an infection.
Previous studies in mice have shown, however, that even genetically identical iPS
cells can
trigger an
immune response after transplantation.
Now, scientists have modified Salmonella bacteria to
trigger a particularly powerful
immune response against human cancer
cells implanted in mice, shrinking the tumors and — for the first time — preventing them from metastasizing.
The 3 - D scaffold effectively recruits and activates the dendritic
cells to
trigger an
immune response against specific
cells, such as cancerous
cells.
In a report to be published in the journal
Cell Host & Microbe online June 11, researchers showed that
immune - system -
triggering TB proteins, or antigens, were able to prompt a larger, prolonged
immune system
response just by being transported from infected dendritic
cells to uninfected ones.
«Our study shows a whole new route, or bypass mechanism, for
triggering the body's adaptive
immune response to TB infection, a means by which infected dendritic
cells cooperate with uninfected dendritic
cells to activate T
cells and respond to the infection,» says infectious disease specialist and study senior investigator Joel Ernst, MD, a professor at NYU Langone Medical Center.
IFN - I
triggers many different
immune responses, but can also speed up the replacement of epithelial
cells.
New findings published in the journal Nature Chemical Biology by UNC School of Medicine scientists show that MRGRPX2, a receptor protein on the surface of mast
cells, can
trigger the
immune system
response that leads to itching associated with some opioids.
«We now have the first marker for the capacity of brain
immune cells to remove toxic materials,» says Haass, «and its increase long before full Alzheimer's dementia shows that there is early neuronal injury that does not yet affect memory, but already
triggers a microglia
response.»
Antigens are flags on the surface of
cells, and they
trigger the
immune response when the flags are foreign.
Receptors on T -
cells recognize antigens, or pieces of other
cells that
trigger an
immune response, particularly antibodies.
The
immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous
cells from the skin.
The same autoimmune
response that
triggered the disease would likely attack new β
cells derived from the patient's own iPS
cells, and a normal
immune response would destroy ES - derived β
cells, which would appear foreign.
Retinal
cell death can be induced by phagocytic
immune cells that infiltrate the tissue in
response to injury or infection, but the molecular signals that
trigger phagocyte invasion are largely unknown.
The vaccine is unique to the individual participant and is engineered to
trigger an
immune system
response to kill tumor
cells that may remain following surgery.
The
immune response triggered by fetal
cells might help the body detect cancer
cells later in life.
In 2008, he joined the group of Caetano Reis e Sousa at the Cancer Research UK (CRUK) London Research Institute and later joined the Francis Crick Institute, where he was awarded Marie Curie and EMBO long - term postdoctoral fellowships to investigate innate
immune receptors and signaling pathways that
trigger dendritic
cell activation and drive T -
cell responses against viruses or tumors.
Peng Zhou at the Wuhan Institution of Virology in China and his colleagues
triggered immune responses in the white blood
cells of mice and Chinese rufous horseshoe bats, which harboured the SARS virus.
To
trigger a vigorous
immune response, antigen - presenting
cells (APCs) put on display chopped - up peptides from pathogens or tumor
cells.
Minguet and her team have discovered that the protein Caveolin - 1 regulates this organization, making it the key to activation of the B
cells and the
triggering of an
immune response.
Wu's team killed the stem
cells with radiation so they wouldn't keep growing and combined them with a substance that helps
trigger an
immune response.
Gene therapy, which often employs viruses to deliver the good genes to a body's target
cells, has been known to
trigger severe
immune responses and was blamed for the death of an 18 - year - old in 1999, who was receiving gene therapy for a hereditary metabolic disorder.
Rather, he was intrigued by its documented ability to dampen the
immune responses triggered by vaginal epithelial
cells when exposed to toxins.
There, the
immune cells interact with liver
cells and
trigger an inflammatory
response that damages the liver tissue and also destabilizes the metabolic activity of the liver
cells.
In the new paper, researchers led by Dr. Torres showed that LPA keeps T
cells inactivated even after they have «seen» a target, or antigen, on a cancer
cell that would normally
trigger an
immune response.
The saliva
triggers an
immune response in which white blood
cells called neutrophils and myeloid
cells rush to the site.
Most importantly, many of the T
cells were able to recognize the tumor
cells directly, demonstrating that the vaccine had
triggered a tumor - specific
immune response that could target the patient's tumor.
On a cellular level, FnEDA
triggered an
immune response in skin
cells, leading to fibrosis.
The cornea and its stromal stem
cells themselves appear to be «
immune privileged,» meaning they don't
trigger a significant
immune response even when transplanted across species, as in the Pitt experiments.
While the understanding of dendritic
cell function is expanding, it is already evident that they have the ability to turn on or turn off areas of the
immune system, thus either
triggering or silencing a
response.
A study published by
Cell Press November 21st in the journal Immunity reveals how HIV - 1 escapes detection by essentially becoming invisible to a patient's
immune system, whereas HIV - 2
triggers protective
immune responses in patients.
Humans with FHL2 may not have a truly naive
immune response to their viral
trigger, as they could possess a pre-existing memory T
cell response to an HLH
trigger without prior exposure to this specific
trigger.
Some not - yet - identified molecule, or combination of molecules, such as proteins, fats, or sugars, made by bacteria cause the
immune system to produce T helper 17
cells (Th17), which
trigger a surge in inflammation as part of the
response to a pathogenic strain.
Chief among them was the finding that in all placental mammals FOXP3 acts through a snippet of DNA called the CNS1 enhancer to
trigger the formation of a cohort of Tregs designated «peripheral» (whereas most Tregs are produced in the thymus gland, which sits between the lungs, a subset of the
cells act as sentinels suppressing runaway
immune responses in the body's peripheral tissues).
A new UC San Francisco study has shown that a cancer - killing («oncolytic») virus currently in clinical trials may function as a cancer vaccine — in addition to killing some cancer
cells directly, the virus alerts the
immune system to the presence of a tumor,
triggering a powerful, widespread
immune response that kills cancer
cells far outside the virus - infected region.
While ZVex primes the
immune system by
triggering the generation of CTLs, GLAAS, by activation of CD4
cells, boosts the
immune response by expanding and enhancing the function of CTLS and other anti-tumor mechanisms.
As fibrin builds up in the brain, it
triggers an
immune response that leads to the degradation of the nerve
cells» myelin sheath, over time contributing to the progression of MS.
This is often enough to halt the infection but the second part of the
immune response is adaptive immunity, when dendritic
cells activate T lymphocytes and
trigger a cascade of
immune reactions, such as the formation of antibodies and killer
cells that clear the infection from the body and form a memory of the invading pathogen.